You may have seen the news about the new Wegovy pill — the oral weight loss tablet that's been all over the media this week. We wanted to give you our honest, clinical take on it so you have the full picture. 💊

The headlines are exciting, but here's what they're leaving out:

🔹 The Wegovy pill contains semaglutide — the same active ingredient as Rybelsus, which has been available as an oral tablet for over 6 years. The main difference is a higher dose (25mg).

🔹 Average weight loss in trials was 13.6–16.6% — meaningful, but significantly less than Mounjaro's 20–22.5%. These are not comparable treatments.

🔹 The higher dose comes with a notably higher rate of nausea and vomiting — something worth knowing before starting.

🔹 Where it does shine: no injections, no refrigeration needed, and a strong option for maintaining weight loss after injectable therapy.

The bottom line? A useful option for the right person — but Mounjaro remains the gold standard for maximum results.

We'll be in touch as soon as the Wegovy pill becomes available in the UK. In the meantime, if you have any questions about your current treatment or want to book a review, just reply here and we'll get you sorted. 😊